Synthace
PrivateLast Round
Series C
Nov 16, 2021
Est. Valuation
$71.3M
Total Funding Raised
$76.37M
Momentum Score
25 /100
Company Overview
Synthace is a biotechnology company that offers a laboratory automation platform aimed at transforming biological experimentation by streamlining data management and facilitating the planning and execution of complex experiments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Workflow Automation, Low-Code/No-Code, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthace Comps
Public and private peers based on sector, stage, and business model.
Synthace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 16, 2021 | ||||
| Series B | Dec 12, 2018 | ||||
| Series A | Sep 19, 2017 | ||||
| Seed | Feb 11, 2015 | ||||
| Seed | Sep 23, 2014 | ||||
Grant | Mar 7, 2013 |
Key People
Founding team and executive leadership
Synthace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series A |
| Horizons Ventures | Series B, Series C |
| Voyagers.io | Series C |
| Biotechnology and Biological Sciences Research Council (BBSRC) | Grant |
| Innovate UK | Grant |
| UK Innovation & Science Seed Fund | Seed |
| Bioeconomy Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Added Charles River Laboratories International as a customer.
- Apr 1, 2026
Added GlaxoSmithKline, a pharmaceutical company, as a customer.
Synthace Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synthace's valuation, stock price, and market status.
